(76 days)
Not Found
No
The summary describes a physical, disposable catheter and does not mention any software, algorithms, or data processing that would indicate the use of AI or ML.
Yes
The device is indicated for patients with urine retention and voiding dysfunction to allow urine to drain, which addresses a health condition and restores a normal bodily function.
No
This device is a catheter used for draining urine, which is a treatment or management function, not a diagnostic one.
No
The device description clearly states it is a sterile, single use, disposable polyurethane catheter, which is a physical hardware device.
No, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In Vitro Diagnostics are medical devices used to examine specimens taken from the human body (like blood, urine, tissue) to provide information for diagnosis, monitoring, or screening.
- Device Function: The SpeediCath Compact Male is a catheter inserted into the body (urethra and bladder) to drain urine. It is a physical device used for a therapeutic purpose (relieving urine retention and PVR), not for analyzing a specimen outside the body.
- Intended Use: The intended use clearly describes a procedure performed on the patient's body, not a test performed on a sample.
Therefore, based on the provided information, the SpeediCath Compact Male is a medical device, but it falls under a different category than In Vitro Diagnostics.
N/A
Intended Use / Indications for Use
SpeediCath Compact Male is indicated for use by patients with urine retention and patients with a post void residual volume (PVR) due to neurogenic and non-neurogenic voiding dysfunction. The catheter is inserted into the urethra to reach the bladder allowing urine to drain. The catheter is for male patients.
Product codes
GBM
Device Description
The SpeediCath Compact Male is a sterile, single use, disposable polyurethane catheter for males. The catheter is pre-lubricated with a hydrophilic coating and immersed in saline solution. To prepare the catheter for use, the cover is removed and the catheter is pulled out of the packaging thereby extending and locking it to its full length. The catheter is then ready to use allowing easy drainage.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Urethra to bladder
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
SpeediCath Compact Male has been tested and complies with relevant sections of ASTM F 623-99, ASTM D1894-11, EN 1616, EN 1617 and EN 1618. Performance Testing included: Flow Rate, Coefficient of Friction, Tensile Strength. SpeediCath Compact Male has been tested and complies with relevant sections of ISO 10993, Biological Evaluation of Medical Devices. Biocompatibility Testing included: Cytotoxicity, Irritation, Sensitization, Colorant Leachable Study.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 876.5130 Urological catheter and accessories.
(a)
Identification. A urological catheter and accessories is a flexible tubular device that is inserted through the urethra and used to pass fluids to or from the urinary tract. This generic type of device includes radiopaque urological catheters, ureteral catheters, urethral catheters, coudé catheters, balloon retention type catheters, straight catheters, upper urinary tract catheters, double lumen female urethrographic catheters, disposable ureteral catheters, male urethrographic catheters, and urological catheter accessories including ureteral catheter stylets, ureteral catheter adapters, ureteral catheter holders, ureteral catheter stylets, ureteral catheterization trays, and the gastro-urological irrigation tray (for urological use).(b)
Classification. (1) Class II (performance standards).(2) Class I for the ureteral stylet (guidewire), stylet for gastrourological catheter, ureteral catheter adapter, ureteral catheter connector, and ureteral catheter holder. The devices subject to this paragraph (b)(2) are exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 876.9.
0
Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the perimeter. Inside the circle is a stylized symbol featuring three human profiles facing to the right, stacked on top of each other, representing the department's focus on health and human well-being.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
January 20, 2015
Coloplast A/s Brian Schmidt Regulatory Affairs Manager 1601 West River Road North Minneapolis, MN 55411
Re: K143182
Trade/Device Name: Speedicath Compact Male Regulation Number: 21 CFR 876.5130 Regulation Name: Urological catheter and accessories Regulatory Class: Class II Product Code: GBM Dated: January 7, 2015 Received: January 8, 2015
Dear Brian Schmidt,
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical devicerelated adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in
1
the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours,
Benjamin R. Fisher -S
Benjamin R. Fisher, Ph.D. Director Division of Reproductive, Gastro-Renal, and Urological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
2
Statement of Indications for Use
510(k) Number (if known): K143182
Device Name: SpeediCath Compact Male
Indications for Use:
SpeediCath Compact Male is indicated for use by patients with urine retention and patients with a post void residual volume (PVR) due to neurogenic and non-neurogenic voiding dysfunction. The catheter is inserted into the urethra to reach the bladder allowing urine to drain. The catheter is for male patients.
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Prescription Use X OR (Per 21 CFR 801.109
Over-The-Counter Use_
(Optional Format 1-2-96)
3
510(k) Summary
SpeediCath Compact Male
(as required per 21 CFR § 807.92)
| The assigned 510(k) number is: | |
|---|---|
| Submitter: | Coloplast Corp |
| 1601 West River Road North | |
| Minneapolis, MN 55411 | |
| Contact Person: | Brian E. Schmidt |
| Regulatory Affairs Manager | |
| Coloplast Corp | |
| 1601 West River Road | |
| Minneapolis, MN 55411 | |
| Office: (612) 302-4987 | |
| Fax: (612) 287-4138 | |
| e-mail: usbes@coloplast.com | |
| Date Prepared: | January 9, 2015 |
Device Name and Classification
| Trade Name: | SpeediCath Compact Male |
|---|---|
| Common Name: | Urinary Catheter for Intermittent Use |
| Classification Name: | Gastroenterology-Urology Devices |
| Product Code: | GBM |
Legal Manufacturer
Coloplast A/S Holtedam 1 DK-3050 Humlebaek Denmark
Device Description
The SpeediCath Compact Male is a sterile, single use, disposable polyurethane catheter for males. The catheter is pre-lubricated with a hydrophilic coating and immersed in saline solution. To prepare the catheter for use, the cover is removed and the catheter is pulled out of the packaging thereby extending and locking it to its full length. The catheter is then ready to use allowing easy drainage.
4
Substantial Equivalence Claim
The proposed SpeediCath Compact Male is substantially equivalent in form and function to Coloplast's SpeediCath Compact Set Male, which was cleared under 510(k) K121458 on October 1, 2012.
SpeediCath Compact Male and the predicate device are sterile, single use catheters for intermittent use with hydrophilic coatings.
Both SpeediCath Compact Male and the predicate device are ready to use catheters with identical hydrophilic coatings immersed in identical saline solution. Furthermore, both SpeediCath Compact Male and the predicate device uses the same type of catheter design: telescope catheter.
The main difference between SpeediCath Compact Male and the predicate device is the packaging configuration and visual appearance. SpeediCath Compact Male does not have a pre-attached urine collection bag like the predicate device. The SpeediCath Compact Male packaging configuration has the same ready to use features as the predicate, and is packaged in a green discrete container instead of a turquoise colored. Equivalent to the predicate device, SpeediCath Compact Male is short in storage and is extended to its full length due to the telescopic extension of the catheter.
Indications for Use
SpeediCath Compact Male is indicated for use by patients with urine retention and patients with a post void residual volume (PVR) due to neurogenic and non-neurogenic voiding dysfunction. The catheter is inserted into the urethra to reach the bladder allowing urine to drain. This catheter is for male patients.
Summary of Testing
SpeediCath Compact Male has been tested and complies with relevant sections of ASTM F 623-99, ASTM D1894-11, EN 1616, EN 1617 and EN 1618.
Performance Testing included:
- . Flow Rate
- Coefficient of Friction ●
- . Tensile Strength
SpeediCath Compact Male has been tested and complies with relevant sections of ISO 10993, Biological Evaluation of Medical Devices.
Biocompatibility Testing included:
- Cytotoxicity
- Irritation ●
- Sensitization ●
- Colorant Leachable Study ●